A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
08/2006
08/24/2006	WO2005009375A3 Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
08/24/2006	WO2004082603A3 Modified heat-generating cosmetic compositions
08/24/2006	US20060189693 Methods of treatment with lxr agonists
08/24/2006	US20060189692 Novel anti-proliferative pharmaceutical composition
08/24/2006	US20060189691 Use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person
08/24/2006	US20060189671 Compounds, compositions, and methods
08/24/2006	US20060189644 Lipid-modified immune response modifiers
08/24/2006	US20060189599 Treating alcohol and or substance abuse by antagonizing alpha 2 adrenergic receptors with weak dopamine blocking
08/24/2006	US20060189520 Treatment of diabetes
08/24/2006	US20060189513 A lactoferrin having an N-terminal lactoferrin variant in combination with an effective amount of an antidiabetic drug useful for decreaing blood levels of glucose and insulin thereby treating diabetes mellitus. monitoring the level of glycosylated hemoglobin (HbA1c); delayed release; hyperglycemia
08/24/2006	US20060188991 Flexible vaccine assembly and vaccine delivery platform
08/24/2006	US20060188989 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
08/24/2006	US20060188956 Relaxin3-gpcr135 complexes and their production and use
08/24/2006	US20060188527 Methods for vaccinating against malaria
08/24/2006	US20060188515 Polypeptides for inducing a protective immune response against staphylococcus aureus
08/24/2006	US20060188512 Active immunization to generate antibodies to solble a-beta
08/24/2006	US20060188473 Compositions and methods for repressing B cell autoantibody secretion and for treating autoimmune disorders
08/23/2006	EP1692444A2 Process for co-spray drying agents with dry silicified mcc
08/23/2006	EP1692254A2 Branched sulfates with improved odor properties and their use in personal care compositions
08/23/2006	EP1692131A2 Methods and compositions for slowing aging
08/23/2006	EP1691836A2 Anti-pecam therapy for metastasis suppression
08/23/2006	EP1691823A2 Transdermal system for sustained delivery of polypeptides
08/23/2006	EP1691820A2 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
08/23/2006	EP1691819A2 Chaperone-based therapy for niemann-pick disease
08/23/2006	EP1691813A2 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals; pharmaceutical
08/23/2006	EP1691806A2 Novel therapeutic method and compositions
08/23/2006	EP1691805A1 The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person
08/23/2006	EP1691801A2 Synergistic anti-cancer compositions
08/23/2006	EP1691797A2 Combination of cyclooxygenase-2 inhibitor and phosphodiesterase 4 inhibitor and method
08/23/2006	EP1691789A2 Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
08/23/2006	EP1691779A2 Treatment of a condition in a mammal with administration of compounds and methods of use thereof
08/23/2006	EP1691777A2 Novel differential imaging method
08/23/2006	EP1691776A2 Treatment of aids
08/23/2006	EP1691766A2 Systems and methods for altering vestibular biology
08/23/2006	EP1691764A2 Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a
08/23/2006	EP1691763A2 Cab molecules
08/23/2006	EP1691761A2 A low-weight ultra-thin flexible radiation attenuation composition
08/23/2006	EP1691758A2 Nutraceutical mangosteen tea
08/23/2006	EP1691746A2 Mucoadhesive drug delivery devices and methods of making and using thereof
08/23/2006	EP1691739A2 Altering the stiffness, size, and/or shape of tissues for breathing disorders and other conditions
08/23/2006	EP1691715A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle
08/23/2006	EP1404309B1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl\| propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy\| phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug
08/23/2006	EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/23/2006	CN1823067A Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
08/23/2006	CN1822861A Stable radiopharmaceutical compositions and methods for preparation
08/23/2006	CN1822850A Treatment or prevention of damage due to radiation exposure.
08/23/2006	CN1822839A Muscarinic acetylcholine receptor antagonists
08/23/2006	CN1822827A Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
08/23/2006	CN1822826A Compounds and methods for delivery of prostacyclin analogs
08/23/2006	CN1822807A Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
08/23/2006	CN1821236A Therapeutic heterocyclic compounds
08/23/2006	CN1821226A Antipicornaviral compounds, their preparation and use
08/23/2006	CN1820754A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/22/2006	US7094431 Method of healing skin wounds in mammals and a composition therefor
08/22/2006	US7094427 Combination immediate release controlled release levodopa/carbidopa dosage forms
08/17/2006	WO2006086653A2 Methods and compositions for the treatment of gastrointestinal disorders
08/17/2006	WO2006064381A3 Protein formulation
08/17/2006	WO2005115422A3 Compositions containing avocado leaf extract for lowering cholesterol levels
08/17/2006	WO2005058237A3 Treatment of aids
08/17/2006	WO2005048923A3 Extended release venlafaxine formulation
08/17/2006	WO2005009376B1 Stable aluminum/zirconium antiperspirant solution
08/17/2006	WO2004110359A3 Fusion proteins for the treatment of cns
08/17/2006	WO2004089284A8 Targets for tumor growth inhibition
08/17/2006	WO2004037160A3 In vitro test for studying compound predicting pharmacologic and/or pharmacokinetic and/or pharmacodynamic parameters of a compound
08/17/2006	US20060185026 Atypical protein kinase c isoforms in disorders of the nervous system and cancer
08/17/2006	US20060183692 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy
08/17/2006	US20060182817 Steroidal sapogenins and their derivatives for treating Alzheimer's disease
08/17/2006	US20060182804 Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
08/17/2006	US20060182755 Novel composition and methods for the treatment of psoriasis
08/17/2006	US20060182753 Vaccines
08/17/2006	US20060182715 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-ss
08/17/2006	CA2596505A1 Methods and compositions for the treatment of gastrointestinal disorders
08/16/2006	EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/16/2006	EP1690519A1 Alpha-glucosidase activity inhibitor
08/16/2006	EP1690238A2 System and method for preparing individualized dosage forms of medicaments
08/16/2006	EP1689781A2 Antibodies to cd44 glycoforms and uses thereof
08/16/2006	EP1689732A2 Cationic substituted benzofurans as antimicrobial agents
08/16/2006	EP1689706A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
08/16/2006	EP1689705A2 Fused ring dicationic anti-protozoan agents and their prodrugs
08/16/2006	EP1689469A2 Package for pharmaceutical formulation
08/16/2006	EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof
08/16/2006	EP1689403A2 Heteroaryl-hydrazone compounds
08/16/2006	EP1689400A2 Novel compound, corresponding compositions, preparation and/or treatment methods
08/16/2006	EP1689397A2 Amelioration of macular degeneration and other ophthalmic diseases
08/16/2006	EP1689395A2 Vinca derivatives
08/16/2006	EP1689393A2 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
08/16/2006	EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof
08/16/2006	EP1689383A2 Novel phosphorus-containing thyromimetics
08/16/2006	EP1689379A2 Methods of treating cancer with hdac inhibitors
08/16/2006	EP1689377A2 Stem cell culture medium and method of using said medium and the cells
08/16/2006	EP1689362A2 Pharmaceutical compounding systems and methods and information management system for same
08/16/2006	EP1689361A2 Therapeutic combinations and methods including irm compounds
08/16/2006	EP1689354A2 Amelioration of cataracts, macular degeneration and other ophthalmic diseases
08/16/2006	EP1689353A2 Recovery of phytonutrients from oils
08/16/2006	EP1689348A2 Oligosaccharide compositions and use thereof in the treatment of infection
08/16/2006	EP1689347A2 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
08/16/2006	EP1689346A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
08/16/2006	EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof
08/16/2006	EP1654003A4 Preventative effects of morinda citrifolia on mammary breast cancer
08/16/2006	EP1626729A4 Compositions and methods for symptomatic relief

1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 295